Baudax Bio, Inc. (BXRXQ) Financial Statements (2024 and earlier)

Company Profile

Business Address 490 LAPP ROAD
MALVERN, PA 19355
State of Incorp. PA
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,25915,89130,34217,740
Cash and cash equivalents5,25915,89130,34217,740
Receivables 33554251273
Inventory, net of allowances, customer advances and progress billings 5,6345,0022,978 
Inventory 5,6345,0022,978 
Other undisclosed current assets(4,881)2,0593,3462,122
Total current assets:6,34723,49436,71720,135
Noncurrent Assets
Operating lease, right-of-use asset  583730
Property, plant and equipment7045,0155,0524,821
Intangible assets, net (including goodwill)2,12723,80526,3812,127
Goodwill2,1272,1272,1272,127
Intangible assets, net (excluding goodwill) 21,67824,254 
Other noncurrent assets 854963  
Other undisclosed noncurrent assets    26,400
Total noncurrent assets:3,68529,78332,01634,078
TOTAL ASSETS:10,03253,27768,73354,213
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,0636,8518,6463,803
Interest and dividends payable116  
Employee-related liabilities3,516  
Accounts payable3,9271,4683,653271
Accrued liabilities2,1361,7514,9933,532
Debt5,6002,222683318
Business combination, contingent consideration, liability9,2046,4168,4673,592
Other liabilities    
Other undisclosed current liabilities593157333 
Total current liabilities:21,46015,64618,1297,713
Noncurrent Liabilities
Long-term debt and lease obligation 1,5196,3098,762455
Long-term debt, excluding current maturities 1,5196,3098,469 
Liabilities, other than long-term debt11,29518,09656,57662,766
Other liabilities 598650  
Operating lease, liability  293455
Business combination, contingent consideration, liability 10,69717,44656,57662,766
Other undisclosed noncurrent liabilities  65 
Total noncurrent liabilities:12,81424,40565,40363,221
Total liabilities:34,27440,05183,53270,934
Equity
Equity, attributable to parent(24,242)13,226(14,799)(16,721)
Common stock1698348794
Additional paid in capital166,646144,33297,03419,405
Accumulated deficit(190,904)(132,089)(112,320)(36,220)
Other undisclosed equity    
Total equity:(24,242)13,226(14,799)(16,721)
TOTAL LIABILITIES AND EQUITY:10,03253,27768,73354,213

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues1,2691,0801,964206
Revenue from related parties  1,964206
Cost of revenue(7,009)(2,445)(1,732) 
Cost of goods and services sold(5,282)   
Gross profit:(5,740)(1,365)232206
Operating expenses(30,003)(51,011)(54,568)(32,519)
Other undisclosed operating income (loss)(21,070)33,370(20,450)(206)
Operating loss:(56,813)(19,006)(74,786)(32,519)
Nonoperating income (expense)(1,982)1,54045(38)
Interest and debt expense (3,856)(1,359) 
Loss from continuing operations before equity method investments, income taxes:(58,795)(21,322)(76,100)(32,557)
Other undisclosed income from continuing operations before income taxes  1,553  
Loss from continuing operations before income taxes:(58,795)(19,769)(76,100)(32,557)
Income tax benefit 17,5943,25215,7426,664
Other undisclosed income from continuing operations    
Loss from continuing operations:(41,201)(16,517)(60,358)(25,893)
Loss before gain (loss) on sale of properties:(16,517)(60,358)(25,893)
Loss from discontinued operations    
Other undisclosed net loss(17,594)(3,252)(15,742)(6,664)
Net loss:(58,795)(19,769)(76,100)(32,557)
Other undisclosed net income attributable to parent    
Net loss attributable to parent:(58,795)(19,769)(76,100)(32,557)
Other undisclosed net loss available to common stockholders, basic (2,422)  
Net loss available to common stockholders, diluted:(58,795)(22,191)(76,100)(32,557)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(58,795)(19,769)(76,100)(32,557)
Comprehensive loss, net of tax, attributable to parent:(58,795)(19,769)(76,100)(32,557)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: